The Brain Tumor Center in the News

This innovative course brought together neurosurgeons, neurologists, and neuropsychologists to explore the multidisciplinary needs of adults and children with neurosurgical disorders.

Babacar Cisse, MD, PhD, describes his amazing journey from Senegal to New York, his struggles to get a foothold in the United States, and his philosophy about taking care of his patients.

Dr. Souweidane and his colleagues at Memorial Sloan Kettering Cancer Center updated the results of the landmark trial testing convection-enhanced delivery (CED) of a drug directly to the site of the deadly brain stem tumor.

The gift will fund a two-year initiative to expand the lab’s cellular and molecular precision medicine approach to pediatric brain tumor therapy.

Her abstract investigates the use of "C’dots" as a vehicle for enhanced drug delivery to the CNS

The Department of Neurological Surgery is pleased to welcome Alexandra Giantini Larsen and Andrew Garton to our residency program

The annual list of “Best Doctors in New York,” published this week by New York magazine, includes eight of our faculty members

The annual list, published each May in the New York Times Magazine, is assembled based on peer nomination, credentials, and achievement.

Babacar Cisse, MD, PhD, assistant professor of neurological surgery and of neuroscience in the Feil Family Brain and Mind Research Institute, has been named as the newest Leonard and Fleur Harlan Clinical Scholar, effective April 1, 2018. The three-year appointment supports an outstanding junior faculty member in the field of neurological surgery and will allow Dr. Cisse to develop his brain tumor research laboratory, which focuses on the development and progression of gliomas.

Babacar Cisse, MD, PhD, spoke to the young audience about the path he took from his childhood in Senegal to his life as a neurosurgeon in New York today.

The award was established in 2015 to support the research efforts of promising neurosurgeon-scientists.

The committee is charged with reviewing and prioritizing Phase 2 and Phase 3 clinical trial concepts, in order to promote the best clinical and translational research for patients with brain cancer.

We are proud to announce the appointments of three new faculty members, who expand our already considerable offerings in the treatment of brain and spine disorders.

This year's list includes 8 of our faculty members

He is one of seven young physicians selected for the program, which fosters professional development and leadership.

Researchers found how it may be possible to stop the progression of a low-grade, survivable glioma into a high-grade, fatal malignancy.

Weill Cornell Medicine is one of only a handful of locations in the United States enrolling patients in this innovative trial for GBM

NewYork-Presbyterian Hospital is the #1 hospital in New York for the 16th year in a row; Neurology/Neurosurgery is ranked #1 in New York and #3 in the nation

Top oncology experts tackle the tough questions about accelerating progress

The board members will contribute $5,000 each to the “summer sprint” in the CBTP lab

Dr. Theodore Schwartz and Dr. Mark Souweidane recently presented at the Second Annual International Congress of the Neurosurgery Department of Ain Shams University (AINAS II) in Cairo. The international meeting, which was organized by the university in collaboration with the Egyptian Society of Neurological Surgery (ESNS), brought together experts from Egypt, Saudi Arabia, Germany, South Korea, Finland, the United Kingdom, and the United States to bring advanced endoscopic neurosurgical training to local surgeons.

Dr. Howard Fine talks with CNN's Rachel Crane about organoids -- miniature brains that will allow researchers to explore new avenues in cancer treatment. 

Dr. Theodore Schwartz recently joined the 2015 Mission: BRAIN trip to Guadalajara, Mexico, where U.S. neurosurgeons provided their expertise to local health care providers and patients. This humanitarian effort, founded in 2011 by Dr. Michael Lawton of UCSF and Dr. Alfredo Quiñones-Hinojosa of Johns Hopkins, brings world-class neurosurgical services and training to under-served hospitals and patients. The project has developed multiple partnerships throughout Mexico and has recently expanded to the Philippines.

Dr. Pannullo will serve on the Strategic Planning and Education and Practice Management Committees.

Dr. Fine is an internationally known neuro-oncologist who has previously served as chief of the neuro-oncology branch of the National Cancer Institute.

New position is the gift of David Barnes and his wife, Dr. Ursel Barnes, who made their donation in gratitude to Dr. Schwartz after he removed a brain tumor that was threatening Mr. Barnes’ senses.

More than 500 participants and hundreds more donors, sponsors, and volunteers came together in the spirit of the project's "powered by families" motto.

Neurosurgeon will bring new clinical trials for malignant brain tumors to Weill Cornell Brain and Spine Center

FDA approval allows Dr. Souweidane to re-open the trial and enroll additional pediatric brain tumor patients.

The Weill Cornell Brain and Spine Center is proud to count six of our neurosurgeons among the Best Doctors listed in New York magazine’s annual Best Doctors issue. This year’s list includes four of our full-time faculty — Dr. Philip E. Stieg, chairman of the department of neurosurgery and neurosurgeon-in-chief; Dr.

Dr. Stieg appeared on the "What Do You Do?" segment to explain what it's like to be a neurological surgeon.

The Weill Cornell Pediatric Brain and Spine Center is now enrolling young patients in a new clinical trial testing intra-arterial infusion of chemotherapy drugs in children with certain recurrent brain tumors, including DIPG

On Saturday, July 27, hundreds of runners and walkers hit the trail for the second annual Miles for Hope “Moving Towards a Cure” race/walk, which benefits the Weill Cornell Pediatric Brain and Spine Center’s research into rare and inoperable brain tumors of childhood and adolescents.

The Weill Cornell Brain and Spine Center is proud to have three of our neurosurgeons included on this year’s list of Best Doctors in New York, as published in this week’s issue of New York magazine.

John Boockvar, M.D., was awarded $100,000 by Voices Against Brain Cancer at last night's 8th Annual Sounding Off for a Cure NY Benefit. The award, which covers the period from July 1, 2013 through June 30, 2014, is to support Dr. Boockvar's work investigating “Intra-arterial delivery to the glioma stem cell niche.”

Theodore Schwartz, M.D., has been named to the editorial board of the Journal of Neurosurgery, the official publication of the American Association of Neurosurgeons (AANS) and considered the leading scholarly journal on neurosurgery in the world.

Dr. John Boockvar has been named by Voices Against Brain Cancer as the winner of the 2013 Gary Lichtenstein Humanitarian Award for his lifetime commitment to finding a cure for malignant brain tumors.

Dr. John Boockvar, former Representative Patrick Kennedy, and biotechnology financial analyst Franklin Berger talk about the state of cancer funding, particularly funding for brain cancer research, on the CNBC show Squawk Box. Watch the video:

Six neurosurgeons from the Weill Cornell Brain and Spine Center have been named to the Castle Connolly list of Top Doctors for the New York metro area.

We're proud to have six of our neurosurgeons on this first edition of the magazine's list of top doctors.

Two neurosurgeons at the Weill Cornell Brain and Spine Center are pioneering an exciting new approach for the treatment of recurrent malignant brain tumors. As reported in this New York Times article published on November 17, 2009, their novel approach to treating these resistant brain tumors is yielding successful results. Follow-up MRI imaging on the treated patients has shown that their tumors have shown a dramatic response to the treatment.